Announced
Synopsis
Cytek, a cell analysis solutions company, to acquire Luminex, a biotechnology company, from DiaSorin, an Italian multinational biotechnology company, for $46.5m. “We are currently working on several projects that will allow DiaSorin to further growth and strengthen our positioning as a specialty player over the next years. To do so, we need to be extremely focused on the core for our future and, therefore, we decided to sell the Flow Cytometry & Imaging business unit to a dedicated, leading player in the space. We are convinced that Cytek will be able to grow it with success in the future,” Angelo Rago, Luminex President.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.